Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-03-22 Sale |
2021-03-23 6:02 pm |
Adamas Pharmaceuticals Inc | ADMS | Prentiss Christopher B Chief Financial Officer |
2,422 | $5.48 | $13,273 | 145,017 (Direct) |
View |
| 2021-02-01 Sale |
2021-02-01 9:39 pm |
Adamas Pharmaceuticals Inc | ADMS | Prentiss Christopher B Chief Financial Officer |
3,821 | $6.36 | $24,302 | 72,439 (Direct) |
View |
| 2021-01-20 Sale |
2021-01-22 5:29 pm |
Adamas Pharmaceuticals Inc | ADMS | Prentiss Christopher B Chief Financial Officer |
2,630 | $4.41 | $11,598 | 76,260 (Direct) |
View |
| 2020-11-02 Sale |
2020-11-02 4:44 pm |
Adamas Pharmaceuticals Inc | ADMS | Prentiss Christopher B Chief Financial Officer |
2,050 | $3.21 | $6,581 | 78,890 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-05-15 Option Award(A) |
2025-03-28 8:20 pm |
N/A N/A |
MANNKIND CORP | MNKD | Prentiss Christopher B Chief Financial Officer |
103,600 | $0 | 103,600 (Direct) |
View |
| 2024-05-15 Option Award |
2024-05-17 9:00 pm |
N/A N/A |
MANNKIND CORP | MNKD | Prentiss Christopher B Chief Financial Officer |
390,600 | $0 | 390,600 (Direct) |
View |
| 2021-11-24 Option Award |
2021-11-24 4:10 pm |
N/A N/A |
Adamas Pharmaceuticals Inc | ADMS | Prentiss Christopher B Chief Financial Officer |
18,750 | $0 | 0 (Direct) |
View |
| 2021-11-24 Equity Swap |
2021-11-24 4:10 pm |
N/A N/A |
Adamas Pharmaceuticals Inc | ADMS | Prentiss Christopher B Chief Financial Officer |
163,767 | $0 | 0 (Direct) |
View |
| 2021-03-02 Option Award |
2021-03-03 4:56 pm |
N/A N/A |
Adamas Pharmaceuticals Inc | ADMS | Prentiss Christopher B Chief Financial Officer |
75,000 | $0 | 147,439 (Direct) |
View |